| T-cell activation profiles distinguish hemophagocytic lymphohistiocytosis and early sepsis V Chaturvedi, RA Marsh, A Zoref-Lorenz, E Owsley, V Chaturvedi, ... Blood, The Journal of the American Society of Hematology 137 (17), 2337-2346, 2021 | 81 | 2021 |
| An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis A Zoref-Lorenz, J Murakami, L Hofstetter, S Iyer, AS Alotaibi, SF Mohamed, ... Blood, The Journal of the American Society of Hematology 139 (7), 1098-1110, 2022 | 61 | 2022 |
| Malignancy-associated haemophagocytic lymphohistiocytosis A Setiadi, A Zoref-Lorenz, CY Lee, MB Jordan, LYC Chen The Lancet Haematology, 2022 | 45 | 2022 |
| Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series O Pasvolsky, A Zoref-Lorenz, U Abadi, KR Geiger, L Hayman, I Vaxman, ... International journal of hematology 109, 553-562, 2019 | 23 | 2019 |
| Iodinated contrast media allergy in patients hospitalized for investigation of chest pain G Topaz, A Karas, N Kassem, Y Kitay-Cohen, D Pereg, L Shilo, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (6), 2059-2064, 2018 | 9 | 2018 |
| Challenges in improving global outcomes for hemophagocytic lymphohistiocytosis A Zoref-Lorenz, MB Jordan Pediatric Hematology and Oncology 38 (3), 191-193, 2021 | 2 | 2021 |
| Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis B Verkamp, A Zoref-Lorenz, B Francisco, P Kieser, J Mack, T Blackledge, ... Blood Advances 7 (23), 7258-7269, 2023 | 1 | 2023 |
| Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT AV Geerlinks, B Scull, C Krupski, R Fleischmann, MA Pulsipher, M Eapen, ... Blood advances 7 (14), 3725-3734, 2023 | 1 | 2023 |
| A case of chronic lymphocytic leukemia complicated by hemophagocytic lymphohistiocytosis: identifying the aberrant immune response A Zoref-Lorenz, M Yuklea, G Topaz, MB Jordan, M Ellis Journal of General Internal Medicine 37 (6), 1542-1546, 2022 | 1 | 2022 |
| A novel index using inflammatory markers improves the diagnosis of hemophagocytic lymphohistiocytosis in patients with hematologic malignancies. A Zoref Lorenz, J Murakami, L Hofstetter, SP Iyer, A Alotaibi, S Mohamed, ... journal of clinical oncology 39 (15_suppl), 7563-7563, 2021 | 1 | 2021 |
| A Novel Inflammatory Index Is Sufficient to Identify Hemophagocytic Lymphohistiocytosis in Adult Patients with Hematologic Malignancies A Zoref-Lorenz, J Murakami, L Hofstetter, SP Iyer, AS Alotaibi, P Miller, ... Blood 136, 1-2, 2020 | 1 | 2020 |
| Serum soluble CD25 and ferritin in distinguishing patients with uncomplicated hematologic malignancies from patients with hematologic malignancies complicated by hemophagocytic … A Zoref Lorenz, L Hofstetter, J Murakami, O Pasvolsky, E Guber, ... Journal of Clinical Oncology 38 (15_suppl), e20072-e20072, 2020 | 1 | 2020 |
| Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab S Chandrakasan, MB Jordan, A Baker, EM Behrens, D Bhatla, M Chien, ... Blood Advances, 2024 | | 2024 |
| Inpatient recognition and management of HLH A Zoref-Lorenz, M Ellis, MB Jordan Hematology 2023 (1), 259-266, 2023 | | 2023 |
| Deep Proteomic Analysis Reveals Shared Terminal Mechanisms for Familial Hemophagocytic Lymphohistiocytosis and Lymphoma-Associated Hyperinflammation A Zoref-Lorenz, U Abadi, R Gurion, A Osnis, J Yacobovich, Y Birger, ... Blood 142, 677, 2023 | | 2023 |
| Treatments and Outcomes of Lymphoma-Associated Hyperinflammation-a Report from the HLH in Adults Working Group for the Histiocyte Society A Zoref-Lorenz, SP Iyer, J Murakami, L Hofstetter, R Prakash, S Weinstein, ... Blood 142, 2537, 2023 | | 2023 |
| Inflammatory Markers in Hemophagocytic Lymphohistiocytosis-a Single Centre Study C Spaner, M Goubran, S Stukas, K Shojania, AM Li, M Sekhon, ... Blood 142, 5359, 2023 | | 2023 |
| PB2039: INFLAMMATORY MARKERS IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS-A SINGLE CENTRE STUDY M Goubran, C Spaner, LI Amanda, A Zoref-Lorenz, M Jordan, LYC Chen, ... HemaSphere 7 (S3), e499209c, 2023 | | 2023 |
| DEEP PROTEOMIC ANALYSIS OF FAMILIAL HLH PATIENT'S SERUM INDICATE THAT IFN-g AND IL-6 JAK-STAT3 SIGNALING DRIVE THE DISEASE PATHOLOGY MB Jordan, A Zoref-Lorenz, P Kieser, G Berger, S Izraeli, J Yacobovich PEDIATRIC BLOOD & CANCER 70, S25-S25, 2023 | | 2023 |
| THE OPTIMIZED HLH INFLAMMATORY (OHI) INDEX IDENTIFIES LYMPHOMA PATIENTS WITH UNEXPECTEDLY HIGH MORTALITY NOT RELATED TO DISEASE PROGRESSION A Zoref-Lorenz, J Murakami, L Hofstetter, U Abadi, S Iye, S Mohamed, ... PEDIATRIC BLOOD & CANCER 70, S50-S51, 2023 | | 2023 |
Pia RaananiInstitute of Hematology, Rabin Medical CenterGeverifieerd e-mailadres voor 012.net.il
